CN111504957A - Application of Victoria blue B and its derivatives in the preparation of probes or inhibitors of isomerized proteins - Google Patents
Application of Victoria blue B and its derivatives in the preparation of probes or inhibitors of isomerized proteins Download PDFInfo
- Publication number
- CN111504957A CN111504957A CN201910097524.XA CN201910097524A CN111504957A CN 111504957 A CN111504957 A CN 111504957A CN 201910097524 A CN201910097524 A CN 201910097524A CN 111504957 A CN111504957 A CN 111504957A
- Authority
- CN
- China
- Prior art keywords
- victoria blue
- protein
- isomerized
- proteins
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N2021/6432—Quenching
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Optics & Photonics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
本发明提供了一种维多利亚蓝B及其衍生物在制备异构化蛋白的探针或抑制剂中的应用,属于生物检测或生物医药技术领域。本发明研究证实:维多利亚蓝B及其衍生物维多利亚蓝R、维多利亚蓝BO能识别或抑制异构化蛋白比如淀粉样蛋白“溶菌酶纤维”或变性蛋白“热变性牛血清蛋白”,与异构化蛋白结合,从而激活维多利亚蓝B及其衍生物的荧光。利用维多利亚蓝B及其衍生物的这一特性,可以将维多利亚蓝B及其衍生物应用于异构化蛋白的探针或抑制剂的制备。
The invention provides the application of Victoria blue B and its derivatives in preparing probes or inhibitors of isomerized proteins, belonging to the technical field of biological detection or biological medicine. The research of the present invention confirms that: Victoria blue B and its derivatives Victoria blue R and Victoria blue BO can recognize or inhibit isomerized proteins such as amyloid "lysozyme fiber" or denatured protein "heat-denatured bovine serum albumin". protein binding, thereby activating the fluorescence of Victoria Blue B and its derivatives. Taking advantage of this characteristic of Victoria Blue B and its derivatives, Victoria Blue B and its derivatives can be used in the preparation of probes or inhibitors of isomerized proteins.
Description
技术领域technical field
本发明属于生物检测或生物医药技术领域,具体涉及一种维多利亚蓝B及其衍生物在制备异构化蛋白的探针或抑制剂中的应用。The invention belongs to the technical field of biological detection or biomedicine, and in particular relates to the application of Victoria blue B and its derivatives in the preparation of probes or inhibitors of isomerized proteins.
背景技术Background technique
异构化蛋白即通过一些外界条件使蛋白的二级结构发生变化后的蛋白,包括淀粉样蛋白、变性蛋白、组装蛋白等。其中,淀粉样蛋白(又叫蛋白纤维)是正常蛋白错误折叠聚集的结果。不同类型的淀粉样蛋白尽管在结构上不具有同源性,但是有一个共同的特点:错误折叠多数是将蛋白的二级结构改变,由α-helix转化为β-sheet,纤维化程度越严重,β-sheet的含量也就越多。Isomerized proteins are proteins whose secondary structure has been changed by some external conditions, including amyloid proteins, denatured proteins, and assembled proteins. Among them, amyloid (also called protein fibrils) is the result of normal protein misfolding and aggregation. Although different types of amyloid proteins have no homology in structure, they have a common feature: most of the misfolding is to change the secondary structure of the protein, from α-helix to β-sheet, the more severe the fibrosis. , the more β-sheet content.
现有很多研究都在寻找或者合成荧光探针来预防纤维的形成,已经报道过很多种类型的小分子可以作为某种淀粉样蛋白特异性识别的探针,最常用于标记淀粉样蛋白的染料有刚果红、THT衍生物、姜黄素衍生物等。他们基本都是和淀粉样蛋白的某个残基结合发荧光,但是也存在一些常见的问题,比如说容易荧光淬灭、特异性差、出现假阳性,甚至灵敏度差等。要从根源上解决淀粉样纤维疾病,需要开发、寻找多种抑制剂,对临床研究有实际的应用作用。现在对于抑制剂的研究比较火热,抑制剂的种类也有很多种,比如:有机或者无机纳米粒子、茶多酚、吲哚等小分子,但是仍然存在抑制机理不明确的问题,主要原因在于蛋白纤维化后的序列不明确,这也是一个有待解决的突破性难题。Many studies have been looking for or synthesizing fluorescent probes to prevent the formation of fibrils. It has been reported that many types of small molecules can be used as probes for the specific recognition of a certain amyloid protein, and the most commonly used dyes for labeling amyloid proteins. There are Congo red, THT derivatives, curcumin derivatives, etc. They basically bind to a certain residue of amyloid and fluoresce, but there are also some common problems, such as easy fluorescence quenching, poor specificity, false positives, and even poor sensitivity. To solve the root cause of amyloid fibrosis, it is necessary to develop and find a variety of inhibitors, which have practical application effects for clinical research. There are many types of inhibitors, such as organic or inorganic nanoparticles, tea polyphenols, indole and other small molecules, but there is still a problem of unclear inhibition mechanism, mainly due to protein fibers The sequence after transformation is not clear, which is also a breakthrough problem to be solved.
发明内容SUMMARY OF THE INVENTION
有鉴于背景技术中存在的问题,本发明的目的在于提供一种维多利亚蓝B及其衍生物在制备异构化蛋白的探针或抑制剂中的应用。In view of the problems existing in the background art, the purpose of the present invention is to provide the application of Victoria blue B and its derivatives in the preparation of probes or inhibitors of isomerized proteins.
本发明提供了一种维多利亚蓝B在制备异构化蛋白的探针或抑制剂中的应用。The present invention provides an application of Victoria blue B in preparing probes or inhibitors of isomerized proteins.
优选的,所述异构化蛋白包括淀粉样蛋白或变性蛋白。Preferably, the isomerized protein includes amyloid or denatured protein.
优选的,所述淀粉样蛋白包括溶菌酶,胰岛素,α-突触核蛋白,Aβ淀粉样蛋白,Tau蛋白,甲状腺素运载蛋白,血清淀粉样蛋白A,胰淀素,凝溶胶蛋白,微球蛋白,催乳素,朊病毒,亨廷顿蛋白,降血钙素,心房肽,载脂蛋白A1,乳凝集素,转变生长因子,半胱氨酸蛋白酶抑制剂和免疫球蛋白轻链中的一种或多种。Preferably, the amyloid includes lysozyme, insulin, α-synuclein, Aβ amyloid, Tau protein, transthyretin, serum amyloid A, amylin, gelsolin, microspheres One or one of protein, prolactin, prion, huntingtin, calcitonin, atrial peptide, apolipoprotein A1, lactagglutinin, transforming growth factor, cystatin and immunoglobulin light chain variety.
优选的,所述变性蛋白包括加热变性蛋白、pH变性蛋白、机械力变性蛋白和超声变性蛋白中的一种或多种;所述变性蛋白的二级结构均发生变化。Preferably, the denatured protein includes one or more of heat denatured protein, pH denatured protein, mechanical force denatured protein and ultrasonic denatured protein; the secondary structure of the denatured protein is changed.
本发明还提供了维多利亚蓝B的衍生物作为异构化蛋白的探针或抑制剂的应用。The present invention also provides the use of derivatives of Victoria Blue B as probes or inhibitors of isomerized proteins.
优选的,所述维多利亚蓝B的衍生物包括维多利亚蓝R或维多利亚蓝BO。Preferably, the derivative of Victoria Blue B includes Victoria Blue R or Victoria Blue BO.
优选的,所述异构化蛋白包括淀粉样蛋白。Preferably, the isomerized protein includes amyloid.
有益效果:本发明提供了一种维多利亚蓝B及其衍生物在制备异构化蛋白的探针或抑制剂中的应用。本发明研究证实:维多利亚蓝B及其衍生物维多利亚蓝R、维多利亚蓝BO能识别或抑制异构化蛋白比如淀粉样蛋白“溶菌酶纤维”或变性蛋白“热变性牛血清蛋白”,与异构化蛋白结合,从而激活维多利亚蓝B及其衍生物的荧光。利用维多利亚蓝B及其衍生物的这一特性,可以将维多利亚蓝B及其衍生物应用于异构化蛋白的探针或抑制剂的制备。Beneficial effects: The present invention provides the application of Victoria blue B and its derivatives in preparing probes or inhibitors of isomerized proteins. The research of the present invention confirms that: Victoria blue B and its derivatives, Victoria blue R and Victoria blue BO, can recognize or inhibit isomerized proteins such as amyloid "lysozyme fibers" or denatured proteins "heat-denatured bovine serum albumin". protein binding, thereby activating the fluorescence of Victoria Blue B and its derivatives. Taking advantage of this characteristic of Victoria blue B and its derivatives, Victoria blue B and its derivatives can be used in the preparation of probes or inhibitors of isomerized proteins.
附图说明Description of drawings
图1为本发明实施例1所述共聚焦测试图及荧光监测溶菌酶生长结果;Fig. 1 is the confocal test chart described in Example 1 of the present invention and the fluorescence monitoring lysozyme growth result;
图2为本发明实施例1所述圆二色谱检测结果;Fig. 2 is the detection result of circular dichroism described in the embodiment of the
图3为本发明实施例1所述Zeta电位测试结果及等温滴定量热仪测试结果;Fig. 3 is the Zeta potential test result and isothermal titration calorimeter test result described in the embodiment of the
图4为本发明实施例1所述透射电子显微镜测试结果;Fig. 4 is the test result of transmission electron microscope described in Example 1 of the present invention;
图5为本发明实施例2所述对维多利亚蓝R和维多利亚蓝BO的测试结果;Fig. 5 is the test result of Victoria blue R and Victoria blue BO described in Example 2 of the present invention;
图6为本发明实施例3所述维多利亚蓝B与加热及不加热牛血清蛋白结合的荧光情况;Fig. 6 is the fluorescence situation of the combination of Victoria blue B and heated and unheated bovine serum albumin according to Example 3 of the present invention;
图7为本发明实施例3所述维多利亚蓝B与溶菌酶纤维的结合情况。Fig. 7 is the combination of Victoria blue B and lysozyme fiber according to Example 3 of the present invention.
具体实施方式Detailed ways
本发明提供了维多利亚蓝B在制备异构化蛋白的探针或抑制剂中的应用。The present invention provides the application of Victoria blue B in preparing probes or inhibitors of isomerized proteins.
本发明所述维多利亚蓝B的化学式如式I所示:The chemical formula of Victoria Blue B of the present invention is shown in formula I:
本发明研究证实:维多利亚蓝B能与异构化蛋白比如淀粉样蛋白“溶菌酶纤维”或变性蛋白“热变性牛血清蛋白”结合,并激活维多利亚蓝B荧光。利用维多利亚蓝B的这一特性,可以将维多利亚蓝B应用于异构化蛋白的检测用探针或检测用试剂盒的制备。所述检测用试剂盒中包括维多利亚蓝B,优选还包括其他可用的溶剂、缓冲液等试剂。The present study confirms that Victoria Blue B can bind to isomerized proteins such as amyloid "lysozyme fibers" or denatured proteins "heat-denatured bovine serum albumin", and activate Victoria Blue B fluorescence. Taking advantage of this property of Victoria Blue B, Victoria Blue B can be applied to the preparation of probes or detection kits for the detection of isomerized proteins. The detection kit includes Victoria Blue B, preferably other available solvents, buffers and other reagents.
本领域对异构化蛋白的检测手段主要是荧光检测,但是相关的染料的种类单一,有待开发新的染料来弥补常用染料的缺点,比如:易淬灭,发射波长短等。在本发明中,所述维多利亚蓝B作为异构化蛋白探针的应用方式优选包括对市场上相关产品中的异构化蛋白(含纤维化、变性、组装形式改变等)进行检测(比如,通过检测异构化蛋白的含量来评价商品质量)。将维多利亚蓝B作为异构化蛋白的检测用探针,具有检出限低,灵敏度高,荧光强度较强,荧光波长较长的优点。The detection method of isomerized protein in this field is mainly fluorescence detection, but the types of related dyes are single, and new dyes need to be developed to make up for the shortcomings of commonly used dyes, such as easy quenching and short emission wavelength. In the present invention, the application of the Victoria Blue B as an isomerized protein probe preferably includes detection of isomerized proteins (including fibrosis, denaturation, changes in assembly form, etc.) in related products on the market (for example, The quality of the product is evaluated by detecting the content of isomerized protein). Using Victoria blue B as a probe for the detection of isomerized proteins has the advantages of low detection limit, high sensitivity, strong fluorescence intensity and long fluorescence wavelength.
同时,本发明还提供了维多利亚蓝B作为异构化蛋白的抑制剂的应用,所述应用优选包括将维多利亚蓝B用于制备异构化蛋白抑制剂。本领域公知,人体中异构化蛋白的产生通常与疾病相关。比如,淀粉样蛋白作为正常蛋白错误折叠聚集的结果,可能引发阿尔茨海默病、帕金森、Ⅱ型糖尿病、朊病毒病等重大疾病。利用维多利亚蓝B与异构化蛋白的结合特性,能有效抑制异构化蛋白活性。At the same time, the present invention also provides the application of Victoria Blue B as an inhibitor of isomerized protein, and the application preferably includes the use of Victoria Blue B to prepare an inhibitor of isomerized protein. It is well known in the art that the production of isomerized proteins in humans is often associated with disease. For example, amyloid, as a result of normal protein misfolding and aggregation, may cause major diseases such as Alzheimer's disease, Parkinson's disease,
除了维多利亚蓝B,本发明还提供了维多利亚蓝B的衍生物作为异构化蛋白的探针或抑制剂的应用。在本发明中,所述维多利亚蓝B的衍生物包括维多利亚蓝R或维多利亚蓝BO。In addition to Victoria Blue B, the present invention also provides the use of derivatives of Victoria Blue B as probes or inhibitors of isomerized proteins. In the present invention, the derivatives of Victoria Blue B include Victoria Blue R or Victoria Blue BO.
所述维多利亚蓝R的化学式如式II所示:The chemical formula of the Victoria Blue R is shown in formula II:
所述维多利亚蓝BO的化学式如式III所示:The chemical formula of the Victoria blue BO is shown in formula III:
本发明依据维多利亚蓝B的结构对其衍生物进行了研究。研究发现:维多利亚蓝R和维多利亚蓝BO对淀粉样蛋白溶菌酶纤维也有一定的抑制作用,与维多利亚蓝B的表现形式类似,抑制发生在淀粉样蛋白溶菌酶纤维的伸长时期。In the present invention, the derivatives of Victoria Blue B are studied based on the structure of Victoria Blue B. The study found that: Victoria blue R and Victoria blue BO also have a certain inhibitory effect on amyloid lysozyme fibers, similar to Victoria blue B, and the inhibition occurred during the elongation of amyloid lysozyme fibers.
此外,与维多利亚蓝B类似,其衍生物维多利亚蓝R,维多利亚BO,维多利亚蓝FBR,维多利亚蓝FGA,维多利亚蓝4R,以及与维多利亚蓝B结构框架类似的染料比如溴甲酚蓝,溴甲酚绿,溴甲酚紫,孔雀石绿等,还有其他染料,比如:芝加哥天蓝6B,喹哪啶红等,也部分可用于溶菌酶、牛胰岛素纤维,CsgA蛋白等淀粉样蛋白或其他类型的变性蛋白检测,与这些异构化蛋白相结合而激发荧光,并且部分可以抑制异构化蛋白中淀粉样蛋白纤维的生长。In addition, similar to Victoria Blue B, its derivatives Victoria Blue R, Victoria BO, Victoria Blue FBR, Victoria Blue FGA, Victoria Blue 4R, and dyes similar to Victoria Blue B structural framework such as bromocresol blue, bromocresol green , bromocresol purple, malachite green, etc., and other dyes, such as: Chicago sky blue 6B, quinaldine red, etc., can also be partially used for lysozyme, bovine insulin fiber, CsgA protein and other amyloid or other types of denaturation Protein detection, combined with these isomerized proteins to stimulate fluorescence, and partially inhibit the growth of amyloid fibrils in the isomerized proteins.
下面结合实施例对本发明提供的技术方案进行详细的说明,但是不能把它们理解为对本发明保护范围的限定。The technical solutions provided by the present invention will be described in detail below with reference to the embodiments, but they should not be construed as limiting the protection scope of the present invention.
实施例1Example 1
本实施例所用各原料来源为:维多利亚蓝B,购买自上海如吉生物科技(上海,中国)。溶菌酶(鸡蛋清),牛血清蛋白,氯化钠(NaCl),Tris,盐酸(HCl),甘氨酸,购买自北京鼎国长生生物技术(北京,中国)。The sources of the raw materials used in this example are: Victoria Blue B, purchased from Shanghai Ruji Biotechnology (Shanghai, China). Lysozyme (egg white), bovine serum albumin, sodium chloride (NaCl), Tris, hydrochloric acid (HCl), glycine, were purchased from Beijing Dingguo Changsheng Biotechnology (Beijing, China).
将上述购买的溶菌酶称取适量溶解于含有80mM氯化钠和70mM甘氨酸(pH=2.7)的缓冲溶液中,使得溶菌酶的终浓度为10μM;用磁力搅拌器加热搅拌,加热温度为65℃,搅拌转数为220rmp,加热6h,得到溶菌酶淀粉样,保存在4℃冰箱中备用。The lysozyme purchased above was weighed and dissolved in a buffer solution containing 80 mM sodium chloride and 70 mM glycine (pH=2.7), so that the final concentration of lysozyme was 10 μM; heated and stirred with a magnetic stirrer, and the heating temperature was 65 ° C , the stirring revolution is 220rmp, heating for 6h to obtain lysozyme amyloid, which is stored in a refrigerator at 4°C for later use.
将上述所购买牛血清蛋白用蒸馏水溶解至浓度为100μM,用金属浴在100℃加热10分钟变性,保存在4℃冰箱中备用。The bovine serum albumin purchased above was dissolved in distilled water to a concentration of 100 μM, denatured by heating at 100° C. for 10 minutes in a metal bath, and stored in a 4° C. refrigerator for later use.
共聚焦测试:Confocal test:
采用从德国蔡司公司购买的LSM710型号的激光共聚焦倒置显微镜观察不加入和加入抑制剂维多利亚B(50μM)对溶菌酶生长为纤维过程的影响。分别取在65℃、220rmp的外界条件下孵育的不同阶段的溶菌酶样品使得最终检测时的浓度为100μM,取好再后加入一定量的染料维多利亚B使得最终两者的终浓度均为20μM。每个样品分别取3uL制片,载玻片要轻放,保证样品均匀铺展到载玻片上。用630nm的激光灯扫描,20×的放大倍数下即可获得以下的共聚焦图。结果见图1-A。其中,上面和下面分别为原始和放大图像。The effects of no addition and addition of the inhibitor Victoria B (50 μM) on the growth of lysozyme into fibers were observed using a laser confocal inverted microscope of model LSM710 purchased from Zeiss, Germany. Take lysozyme samples at different stages incubated at 65 °C and 220 rmp, respectively, to make the
荧光监测溶菌酶的生长:Fluorescence monitoring of lysozyme growth:
用从日本岛津公司购买的型号为RF-5301PC的荧光光谱仪测维多利亚蓝B识别溶菌酶纤维的荧光强度,在纤程生长过程中不定时定量的取样,使最终检测的终浓度为1mM。在取样结束后每个阶段的样品中加入1mM的维多利亚蓝B,使其终浓度为20μM,用从晔辉玻璃仪器厂购买的狭缝3mm的石英池子测其荧光强度,激发波长和发射波长分别为650nm和710nm,测量时激发和发射狭缝分别5mm和10mm。重复做以上实验三组,扣除偏差大的点,做成曲线及折线图,结果见图1-B,其中,曲线代表纤维生长情况。The fluorescence intensity of Victoria blue B to identify lysozyme fibers was measured with a fluorescence spectrometer of model RF-5301PC purchased from Shimadzu Corporation of Japan, and quantitative sampling was performed irregularly during the fiber growth process, so that the final concentration of the final detection was 1 mM. After sampling, 1 mM Victoria blue B was added to the samples at each stage to make the
圆二色谱检测:Circular dichroism detection:
用从Biologic购买的圆二色谱仪分别检测加入和不加入抑制剂维多利亚蓝B的不同阶段的样品。每个取样100μL,溶解在200mM的Tris-HCl缓冲溶液中,使其终浓度为10μM。用1mm的石英池子,扫描起始波长为190nm,终止波长为260nm,扫描时间间隔为10s,每个光谱平均扫三次。检测结果如图2所示。其中,图2-A和图2-B分别为不加抑制剂以及加入维多利亚蓝B(150μM)的圆二谱图,图2-C和图2-D分别为与图2-A和图2-B相对应的α-helix和β-sheet含量统计图。Samples at different stages with and without the addition of the inhibitor Victoria Blue B were tested with a circular dichroism instrument purchased from Biologic. 100 μL of each sample was dissolved in 200 mM Tris-HCl buffer solution to a final concentration of 10 μM. Using a 1 mm quartz cell, the starting wavelength of scanning is 190 nm, the ending wavelength is 260 nm, the scanning time interval is 10 s, and each spectrum is scanned three times on average. The test results are shown in Figure 2. Among them, Figure 2-A and Figure 2-B are the circular digraphs without inhibitor and Victoria blue B (150μM), respectively, Figure 2-C and Figure 2-D are the same as Figure 2-A and Figure 2 -B corresponding α-helix and β-sheet content statistics.
Zeta电位测试:Zeta Potential Test:
用从英国的莫尔文仪器有限公司购买的ZEN3600型号的马尔文粒度仪监测成熟纤维、染料以及纤维与染料结合后的Zeta电位,纤维的终浓度为100μM,染料的终浓度为20μM,均用pH=7.4的200mM Tris-HCl缓冲溶液稀释。Zeta电位测试结果如图3-A所示。The Zeta potential of mature fibers, dyes, and fibers combined with dyes was monitored with a ZEN3600 Malvern particle sizer purchased from Malvern Instruments Ltd., UK. The final concentration of the fibers was 100 μM and the final concentration of the dye was 20 μM. Diluted in 200 mM Tris-HCl buffer pH=7.4. The Zeta potential test results are shown in Figure 3-A.
等温滴定量热仪测试:Isothermal titration calorimeter test:
用从美国通用电气公司购买的MicroCal ITC20型号的等温滴定量热仪测量维多利亚蓝B滴定溶菌酶的系列热力学参数。溶菌酶溶解在含有70mM的甘氨酸及80mM的氯化钠PH=2.7的缓冲溶液中在65℃,220rmp的条件下加热4h,维多利亚蓝B用水溶解至浓度为10μM,并取适量注入到样品池中,取溶菌酶加热搅拌后的样品用水稀释到50μM,用注射器吸取备用,然后在1000rmp的条件下搅拌,每隔120s滴定1μL的溶菌酶纤维到维多利亚中,即可获得溶菌酶纤维滴定维多利亚蓝B的等温滴定的数据,再根据拟合曲线即可计算结合常熟,反应热等热力学参数。等温滴定量热仪测试结果如图3-B所示。其中,上下图分别代表结合等温线和积分热以及相应的拟合线。A series of thermodynamic parameters of Victoria blue B titration of lysozyme were measured with an isothermal titration calorimeter, model MicroCal ITC20, purchased from General Electric Company, USA. Lysozyme was dissolved in a buffer solution containing 70 mM glycine and 80 mM sodium chloride pH=2.7, heated at 65°C, 220 rmp for 4 h, Victoria blue B was dissolved in water to a concentration of 10 μM, and an appropriate amount was injected into the sample pool , take the heated and stirred sample of lysozyme and dilute it to 50 μM with water, draw it with a syringe for use, then stir under the condition of 1000 rmp, and titrate 1 μL of lysozyme fiber into Victoria every 120s to obtain lysozyme fiber titration Victoria Blue B The isothermal titration data, and then according to the fitting curve can calculate the combination of Changshu, reaction heat and other thermodynamic parameters. The test results of the isothermal titration calorimeter are shown in Figure 3-B. Among them, the upper and lower figures represent the binding isotherm and integral heat and the corresponding fitted line, respectively.
透射电子显微镜测试:Transmission Electron Microscopy Testing:
采用日本生产的JEM型号的透射电子显微镜,观察上述加热4h的样品,取适量的样品滴在300目的铜网上,并用0.01μg/50μ的磷钨酸染样品,之后用超纯水洗干净背景即可。在纤维性颤动发生60、90、120和240min时采集样本,投射结果见图4。图4代表了溶菌酶纤维颤动在没有(上半部分)和存在(下半部分)维多利亚蓝B(50μM)的情况下,蛋白质聚集的形态变化情况。A JEM model transmission electron microscope produced in Japan was used to observe the above-mentioned samples heated for 4 hours. An appropriate amount of samples were dropped on a 300-mesh copper mesh, and the samples were stained with 0.01 μg/50 μ phosphotungstic acid, and then washed with ultrapure water to clean the background. . Samples were collected at 60, 90, 120, and 240 min of fibrillation, and projection results are shown in Figure 4. Figure 4 represents the morphological changes of protein aggregates in the absence (top half) and presence (bottom half) of Victoria blue B (50 μM) for lysozyme fibrillation.
实施例2Example 2
按照实施例1的方法,对维多利亚蓝R和维多利亚蓝BO进行测试,结果如图5所示。其中,图5-A表示在纤维生长的条件下加入不同浓度的抑制剂维多利亚蓝BO的纤维生长情况;图5-B表示在纤维生长的条件下加入不同浓度的抑制剂维多利亚蓝R的纤维生长情况;图5-C、5-D和5-E分别表示不加入维多利亚蓝BO或维多利亚蓝R、加入维多利亚蓝BO(150μM)和加入维多利亚蓝R(150μM)的圆二色谱图;图5-F、5-G和5-H分别表示与图5-C、5-D和5-E依次对应的α-helix和β-sheet含量统计图。According to the method of Example 1, Victoria Blue R and Victoria Blue BO were tested, and the results are shown in FIG. 5 . Among them, Figure 5-A shows the fiber growth under the condition of fiber growth by adding different concentrations of the inhibitor Victoria Blue BO; Figure 5-B shows the fiber growth by adding different concentrations of the inhibitor Victoria Blue R under the condition of fiber growth situation; Figures 5-C, 5-D and 5-E represent circular dichroism chromatograms without the addition of Victoria Blue BO or Victoria Blue R, Victoria Blue BO (150 μM) and Victoria Blue R (150 μM) additions, respectively; Figure 5- F, 5-G and 5-H represent the α-helix and β-sheet content charts corresponding to Fig. 5-C, 5-D and 5-E respectively.
图5表明:维多利亚蓝R和维多利亚蓝BO对溶菌酶纤维同样具有抑制作用,且能作为溶菌酶纤维的探针使用。Figure 5 shows that: Victoria blue R and Victoria blue BO also have inhibitory effects on lysozyme fibers, and can be used as probes for lysozyme fibers.
实施例3Example 3
利用荧光检测法,检测维多利亚蓝B与加热及不加热的牛血清蛋白结合的荧光情况,结果如图6所示。其中,图6-A为荧光成像仪直观显示图,1管为维多利亚蓝B+加热的牛血清蛋白,2管为为维多利亚蓝B+牛血清蛋白,3管为维多利亚蓝B,4管为加热的维多利亚蓝B。图6-B为不同处理组的荧光显色情况。Using the fluorescence detection method, the fluorescence of Victoria blue B binding to heated and unheated bovine serum albumin was detected, and the results are shown in Fig. 6 . Among them, Figure 6-A is the visual display of the fluorescence imager, 1 tube is Victoria Blue B + heated BSA, 2 tubes are Victoria Blue B + BSA, 3 tubes are Victoria Blue B, and 4 tubes are heated Victoria Blue blue B. Figure 6-B shows the fluorescence color development of different treatment groups.
图6表明:维多利亚蓝B与原蛋白结合不发光,与加热变性后的牛血清蛋白结合发红色荧光,可用作加热变性的牛血清蛋白探针。Figure 6 shows that: Victoria blue B does not emit light when combined with the original protein, and emits red fluorescence when combined with heat-denatured bovine serum albumin, which can be used as a heat-denatured bovine serum albumin probe.
利用荧光光谱检测法,检测维多利亚蓝B监测溶菌酶纤维的发荧光强度情况,结果如图7所示。其中,图7-A为维多利亚蓝B与溶菌酶纤维加入浓度的关系;由图7-A可以算出:维多利亚蓝B能检测溶菌酶纤维的检出限为0.3019μM。图7-B为维多利亚蓝B作为荧光探针对溶菌酶纤维的检测情况;由从图7-B可以得出线性相关系数为R2=0.9985,所以溶菌酶纤维的浓度在0-20μM范围内,维多利亚蓝B检测较灵敏。The fluorescence intensity of the lysozyme fibers was monitored by detecting Victoria blue B by using the fluorescence spectrum detection method, and the results are shown in Fig. 7 . Among them, Figure 7-A shows the relationship between Victoria Blue B and the concentration of lysozyme fibers added; from Figure 7-A, it can be calculated that the detection limit of Victoria Blue B for detecting lysozyme fibers is 0.3019 μM. Figure 7-B shows the detection of lysozyme fibers by Victoria blue B as a fluorescent probe; from Figure 7-B, it can be concluded that the linear correlation coefficient is R 2 =0.9985, so the concentration of lysozyme fibers is in the range of 0-20 μM , Victoria blue B detection is more sensitive.
以上所述仅是本发明的优选实施方式,应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明原理的前提下,还可以做出若干改进和润饰,这些改进和润饰也应视为本发明的保护范围。The above are only the preferred embodiments of the present invention. It should be pointed out that for those skilled in the art, without departing from the principles of the present invention, several improvements and modifications can be made. It should be regarded as the protection scope of the present invention.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910097524.XA CN111504957B (en) | 2019-01-31 | 2019-01-31 | Application of Victoria blue B and derivatives thereof in preparation of probe or inhibitor of isomerized protein |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910097524.XA CN111504957B (en) | 2019-01-31 | 2019-01-31 | Application of Victoria blue B and derivatives thereof in preparation of probe or inhibitor of isomerized protein |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111504957A true CN111504957A (en) | 2020-08-07 |
CN111504957B CN111504957B (en) | 2021-12-03 |
Family
ID=71868877
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910097524.XA Expired - Fee Related CN111504957B (en) | 2019-01-31 | 2019-01-31 | Application of Victoria blue B and derivatives thereof in preparation of probe or inhibitor of isomerized protein |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111504957B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN118987235A (en) * | 2024-10-24 | 2024-11-22 | 山东第二医科大学 | Application of nitrogen-doped carbon dot and semi-xylenol orange composition in preparation of bovine insulin fibrosis inhibitor |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1415074A (en) * | 1999-12-29 | 2003-04-30 | 美国氰胺公司 | Method of detection of amyloidogenic proteins |
CN1617884A (en) * | 2001-12-13 | 2005-05-18 | Posco公司 | β-amyloid-binding factor and its inhibitors |
WO2009134147A1 (en) * | 2008-05-02 | 2009-11-05 | Pronova Biopharma Norge As | Lipid compositions containing derivatives of epa and dha an their use thereof |
CN109045005A (en) * | 2018-08-07 | 2018-12-21 | 天津科技大学 | It is fast green to inhibit the purposes in beta-amyloid aggregation |
-
2019
- 2019-01-31 CN CN201910097524.XA patent/CN111504957B/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1415074A (en) * | 1999-12-29 | 2003-04-30 | 美国氰胺公司 | Method of detection of amyloidogenic proteins |
CN1617884A (en) * | 2001-12-13 | 2005-05-18 | Posco公司 | β-amyloid-binding factor and its inhibitors |
WO2009134147A1 (en) * | 2008-05-02 | 2009-11-05 | Pronova Biopharma Norge As | Lipid compositions containing derivatives of epa and dha an their use thereof |
CN109045005A (en) * | 2018-08-07 | 2018-12-21 | 天津科技大学 | It is fast green to inhibit the purposes in beta-amyloid aggregation |
Non-Patent Citations (2)
Title |
---|
WAI-HONG LEUNG等人: "《Amyloid Fibrils as Rapid and Efficient Nano-biosorbents for Removal of Dye Pollutants》", 《RSC ADVANCES》 * |
李振华: ""蛋白变性、纤维化的检测及其生物材料应用"", 《中国优秀硕士学位论文全文数据库 工程科技Ⅰ辑》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN118987235A (en) * | 2024-10-24 | 2024-11-22 | 山东第二医科大学 | Application of nitrogen-doped carbon dot and semi-xylenol orange composition in preparation of bovine insulin fibrosis inhibitor |
CN118987235B (en) * | 2024-10-24 | 2025-01-24 | 山东第二医科大学 | Application of a composition of nitrogen-doped carbon dots and hemi-xylenol orange in the preparation of bovine insulin fibrosis inhibitor |
Also Published As
Publication number | Publication date |
---|---|
CN111504957B (en) | 2021-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Fusco et al. | Structural basis of synaptic vesicle assembly promoted by α-synuclein | |
Bacskai et al. | Fluorescence resonance energy transfer determinations using multiphoton fluorescence lifetime imaging microscopy to characterize amyloid-beta plaques | |
Xia et al. | Visual and fluorescent assays for selective detection of beta-amyloid oligomers based on the inner filter effect of gold nanoparticles on the fluorescence of CdTe quantum dots | |
Nilsson | Techniques to study amyloid fibril formation in vitro | |
Baldwin et al. | Probing dynamic conformations of the high-molecular-weight αB-crystallin heat shock protein ensemble by NMR spectroscopy | |
Dhavale et al. | Structure of alpha-synuclein fibrils derived from human Lewy body dementia tissue | |
Xu et al. | Hen egg white lysozyme fibrillation: a deep‐UV resonance Raman spectroscopic study | |
Ramachandran et al. | Evidence for the existence of a secondary pathway for fibril growth during the aggregation of tau | |
Thirunavukkuarasu et al. | Multiparametric fluorescence detection of early stages in the amyloid protein aggregation of pyrene-labeled α-synuclein | |
CN106916822B (en) | Method for detecting aflatoxin B1 by using aptamer molecular switch | |
Nag et al. | A folding transition underlies the emergence of membrane affinity in amyloid-β | |
Ranjan et al. | Differential copper binding to alpha-synuclein and its disease-associated mutants affect the aggregation and amyloid formation | |
EP4180816A2 (en) | Immunological solid phase assay with spatially resolved signal (sfida) for quantification of at least 2 protein aggregates | |
CN105651752A (en) | Detection method of amyloid protein | |
Khan et al. | Cationic gemini surfactant (16-4-16) interact electrostatically with anionic plant lectin and facilitates amyloid fibril formation at neutral pH | |
CN114858898A (en) | Fluorescence/electrochemistry double-signal mode biosensor and construction method and application thereof | |
CN111504957A (en) | Application of Victoria blue B and its derivatives in the preparation of probes or inhibitors of isomerized proteins | |
Yasuda et al. | Rapid construction of fluorescence quenching-based immunosensor Q-bodies using α-helical coiled-coil peptides | |
CN107247149A (en) | A kind of dermatophagoides pteronyssinus specific IgE half-quantitative detection kit and application thereof | |
Kundel et al. | Shedding light on aberrant interactions–a review of modern tools for studying protein aggregates | |
US20140024813A1 (en) | Binding of pathological forms of proteins using conjugated polyelectrolytes | |
CN111630382A (en) | Assays, methods and treatments for alpha-synucleinopathies | |
US10591486B2 (en) | Methods and tools for detecting interactions in eukaryotic cells using microtubule structures and dynamics | |
CN111700897B (en) | Application of Crocetin G and its derivatives in the preparation of amyloid probes or inhibitors | |
Szikora et al. | Superresolution microscopy of drosophila indirect flight muscle sarcomeres |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20211203 |
|
CF01 | Termination of patent right due to non-payment of annual fee |